Astellas: Astellas Beats Bid by Lupin, Zydus to Nix Myrbetriq ER Patent
Astellas Pharma Inc. defeated two generic-drug makers' key invalidity defenses over a patent for Myrbetriq ER in a long-running clash over copycat versions of the overactive-bladder treatment.
Read full article »
Astellas Pharma is a Japan-based multinational pharmaceutical company that develops and commercializes novel therapeutics for the treatment of a range of diseases.
Read more